Response of Patient-Derived Non-Small Cell Lung Cancer Xenografts to Classical and Targeted Therapies Is Not Related to Multidrug Resistance Markers

<table>mRNA expression of <i>bcrp, lrp, mdr1,</i> and <i>mrp1</i> after short-term treatment in xenografts 7406, 7433, 7700, and 7747. Treatment was performed for three consecutive days. Three tumor samples per group were taken 24 hours after last treatment.</table>

Journal of Oncology

fig1

Figure 1

Figure 1: Response of Patient-Derived Non-Small Cell Lung Cancer Xenografts to Classical and Targeted Therapies Is Not Related to Multidrug Resistance Markers 

Figure 1 | Response of Patient-Derived Non-Small Cell Lung Cancer Xenografts to Classical and Targeted Therapies Is Not Related to Multidrug Resistance Markers 